Cryptococcal meningitis

Br J Hosp Med (Lond). 2017 Aug 2;78(8):C125-C127. doi: 10.12968/hmed.2017.78.8.C125.

Authors

Damien K Ming¹, Thomas S Harrison²

Affiliations

¹ Academic Clinical Fellow, Department of Infection and Immunity, Imperial College London, London W12 0HS.
² Professor of Infectious Diseases and Medicine, Institute of Infection and Immunity, St George's University of London, London.

PMID: 28783390
DOI: 10.12968/hmed.2017.78.8.C125

No abstract available

MeSH terms

Amphotericin B / administration & dosage*
Antifungal Agents / administration & dosage
Brain / diagnostic imaging
Cryptococcus gattii / isolation & purification*
Cryptococcus neoformans / isolation & purification*
Deoxycholic Acid / administration & dosage*
Diagnosis, Differential
Drug Combinations
Early Diagnosis
Fluconazole / administration & dosage*
HIV Infections* / complications
HIV Infections* / diagnosis
Humans
Immunocompromised Host
Meningitis, Cryptococcal* / diagnosis
Meningitis, Cryptococcal* / etiology
Meningitis, Cryptococcal* / physiopathology
Meningitis, Cryptococcal* / therapy
Patient Care Management / methods

Substances

Antifungal Agents
Drug Combinations
Deoxycholic Acid
Amphotericin B
amphotericin B, deoxycholate drug combination
Fluconazole